ARTICLE | Company News
Ferring, Intralytix deal
August 24, 2015 7:00 AM UTC
The companies partnered to develop bacteriophage therapies for inflammatory bowel disease (IBD). Intralytix will assist Ferring in producing and manufacturing the bacteriophages for use in clinical tr...